Paladin Labs Inc.

Acted for Paladin Labs Inc. in connection with its acquisition by Endo Health Solutions Inc. in a stock and cash transaction valued at approximately $3 billion.

Searchlight Pharma Inc.

Acted for the shareholders of Searchlight Pharma Inc., a top-growth Canadian specialty and innovative branded pharmaceutical company, in connection with the sale of their 100% interest to Apotex Inc.

Knight Therapeutics Inc.

Acted for a wholly owned subsidiary of Knight Therapeutics Inc., in the US$125 million cash sale of its Neglected Tropical Disease Priority Review Voucher, which was granted by the U.S. Food and Drug Administration with the approval of Impavidor (miltefosine) for treatment of patients with visceral, mucosal and cutaneous leishmaniasis, to Gilead Sciences, Inc.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. in its transformative acquisition of all of the issued and outstanding shares of Biotoscana Investments S.A., a Luxembourg company listed on the Brazilian stock exchange, for an aggregate purchase price of $369 million.

Kimco Realty Corporation

Acted for Kimco Realty Corporation in connection with the sale of its interests in 22 shopping centres to RioCan Real Estate Investment Trust for a purchase price of $715 million.

The Cadillac Fairview Corporation Limited

Acted for The Cadillac Fairview Corporation Limited with respect to the establishment of a joint venture for the development of Tour des Canadiens 2, a 49 storey residential condominium building located across from the Bell Centre in the heart of downtown Montréal and represented the joint venture, Tour des Canadiens 2 S.E.C., in connection with that development. Davies also represented The Cadillac Fairview Corporation Limited in the establishment of a joint venture in the development of Tour des Canadiens 3, a 55-storey residential condominium building, and acted for the joint venture, Tour des Canadiens 3 S.E.C., in that development. 

Canadian Forum Investments Inc.

Acted for Canadian Forum Investments Inc. in its acquisition of the Montreal Forum historic property in a transaction valued at $45.2 million.

Kimco Realty Corporation

Acted for Kimco Realty Corporation in connection with the sale by its affiliates of co-ownership interests and partnership interests in a portfolio of 18 shopping centres located in Alberta and British Columbia to Anthem Properties Group Ltd. for $413 million dollars.

Family Shareholders of Dorel Industries Inc.

Acting for the controlling family shareholders, who partnered with Cerberus Capital Management, L.P. in the privatization of Dorel Industries Inc., a TSX-listed company, by way of plan of arrangement. 

Rosenbloom Groupe Inc. and Hymopack Ltd.

Acted for Rosenbloom Groupe Inc. and Hymopack Ltd. in the sale of 100% of their equity interests to wholly owned subsidiaries of ProAmpac Packaging Canada Inc.

Altus Formulation Inc.

Acted for Altus Formulation Inc. in its joint venture agreement with Tetra Bio-Pharma Inc. under which the two companies will work together to develop a series of cannabinoid-receptor targeted therapeutics addressing multiple areas of high unmet need.

TALLC Corporation Inc.

Acted for TALLC Corporation Inc., a Montréal-based developer of ophthalmic medicines, regarding its strategic collaboration and licensing agreement with IACTA Pharmaceuticals for the use and future clinical development of TALLC's proprietary SmartCelle micellar technology, a novel platform for pan-ocular drug delivery, for future clinical development.

Searchlight Pharma Inc.

Acted for Searchlight Pharma Inc., a Montréal-based specialty healthcare company, in its acquisition of ERFA Canada 2012 Inc., a distributor of niche pharmaceutical products across Canada that addresses underserved medical indications.

Knight Therapeutics Inc.

Acted for Knight Therapeutics Inc. (TSX: GUD), a pan-America specialty pharmaceutical company, in its acquisition from Novartis of the exclusive rights to manufacture, market and sell Exelon (rivastigmine patch, capsules and solution) in Canada and Latin America, for the purchase price of US$168 million and an additional milestone payment of up to US$12 million on the achievement of certain conditions.

Ayana Pharma Ltd.

Advising Ayana Pharma Ltd. on various commercial matters.

Faubourg Boisbriand Shopping Centre Holdings Inc. (Kimco Realty Corporation)

Acted for Faubourg Boisbriand Shopping Centre Holdings Inc. (a joint venture among Kimco Realty Corporation, Cherokee Partners and Sterling Centrecorp) in connection with a $165 million construction credit facility in respect of the Faubourg Boisbriand lifestyle retail complex in Boisbriand, Québec.

Dealmakers adapt to U.S. tax-inversion restrictions – Lexpert

Apr. 29, 2016 - In a Lexpert article exploring how advance knowledge of the U.S. Treasury Department’s anti-inversion regulations has lessened their impact, Davies partner Hillel Rosen discusses the M&A boom in life sciences. “We’re reading about inversion, but the...